Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
Overview of attention for article published in Lancet Oncology, December 2012
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- news
- 2 news outlets
- policy
- 2 policy sources
- 9 X users
- patent
- 2 patents
- f1000
- 1 research highlight platform
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 163 Mendeley
- citeulike
- 1 CiteULike